Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

News SummaryMost relevantAll newsSector news 

Walgreen Company : Walgreen April Same-Store Sales Fall Bigger-Than-Expected 6.4%

share with twitter share with LinkedIn share with facebook
share via e-mail
05/03/2012 | 02:39pm CEST

Walgreen Co.'s (WAG) April same-store sales fell a bigger-than-expected 6.4%--marking the fourth straight month of declines--as the drug-store chain's loss of Express Scripts Holding Co.'s (ESRX) members continued to hamper results.

Analysts polled by Thomson Reuters expected April same-store sales to fall 5.1%.

A conflict between Walgreen and Express Scripts over new contract terms erupted publicly last June, and Walgreen said it wouldn't be part of the pharmacy-benefits manager's network when their deal expired in 2011. The benefit manager's clients now have to go elsewhere to fill prescriptions.

Total sales fell 3.7% to $5.78 billion last month.

April same-pharmacy sales decreased 8.9% and missed the analysts' projected 8.6% decline.

Total pharmacy sales fell 6.3%. Prescriptions filled at same-stores declined 7.8% in April, reflecting the loss of Express Scripts members, a lower incidence of flu and more generic drug introductions. Prescriptions processed by Express Scripts comprised 12.6% of Walgreen's prescriptions a year earlier.

In the front of the store, same-store sales slipped fell 2.2% last month, compared with the analysts' flat front-end same-store sales forecast.

Total front-end sales slipped 0.5%. Customer traffic at same-stores fell 3% and average basket size increased 0.8%.

Walgreen reported in March its fiscal second-quarter earnings fell 7.7% as its exit from Express Scripts's network and a mild cold and flu season offset a 0.8% pop in total sales.

Shares closed Wednesday at $34.15 and were inactive premarket. The stock has gained 3.3% since the beginning of the year.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
React to this article
05:55p WALGREENS : and U.S. Senator John Cornyn Encourage Dallas / Fort Worth Area Resi..
04:40p WALGREENS BOOTS ALLIANCE : Independent' pharmacist's letter edited by Boots seni..
04/28 WALGREENS BOOTS ALLIANCE : A Mild Flu Season for Most of U.S., but Arizona, Texa..
04/25 WALGREENS : Makes Life Saving Naloxone Available Without Prescription in Alabama..
04/25 WALGREENS BOOTS ALLIANCE : Leads Fight against Prescription Drug Abuse in Califo..
04/25DJKKR Swings to First-Quarter Loss
04/22DJValeant Finalizing Contract With Perrigo's Joseph Papa as Next CEO -- 2nd Upd..
04/22 WALGREENS : Leads Fight Against Prescription Drug Abuse in California with New P..
04/22DJValeant Is Near Naming New CEO -- WSJ
04/21 RITE AID : Reports Fiscal 2016 Fourth Quarter and Full Year Results
News chart
Full-screen chart
Income Statement Evolution
More Financials